Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
specificA chronic myeloid leukemia, BCR-ABL1 positive that is resistant to treatment.
5
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive(5)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 60.0 |
| 2 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 60.0 |
| 3 | OHSU Knight Cancer InstitutePortland, OR NCI Comprehensive | 60.0 |
| 4 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive | 60.0 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 60.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →